Itron, Inc. (NASDAQ:ITRI) Receives $95.60 Consensus Price Target from Brokerages

Shares of Itron, Inc. (NASDAQ:ITRI) have earned a consensus recommendation of “Moderate Buy” from the twelve analysts that are presently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $95.60.

Several research analysts have recently weighed in on the company. Piper Sandler lowered their target price on Itron from $105.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday, April 11th. JPMorgan Chase & Co. boosted their price objective on Itron from $77.00 to $92.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 13th. TheStreet raised Itron from a “c” rating to a “b-” rating in a research note on Monday, February 26th. Oppenheimer raised shares of Itron from a “market perform” rating to an “outperform” rating and set a $81.00 target price on the stock in a research note on Friday, January 19th. Finally, TD Cowen lifted their target price on Itron from $107.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, March 13th.

Itron Stock Up 2.0 %

Shares of ITRI stock opened at $91.46 on Friday. The stock has a 50 day moving average of $88.21 and a 200 day moving average of $75.27. The company has a current ratio of 1.95, a quick ratio of 1.43 and a debt-to-equity ratio of 0.34. The stock has a market cap of $4.19 billion, a P/E ratio of 43.55, a P/E/G ratio of 0.99 and a beta of 1.41. Itron has a twelve month low of $50.60 and a twelve month high of $96.73.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Monday, February 26th. The scientific and technical instruments company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.48. Itron had a net margin of 4.46% and a return on equity of 12.27%. The firm had revenue of $577.17 million for the quarter, compared to the consensus estimate of $569.90 million. During the same period last year, the firm posted $0.71 earnings per share. The company’s revenue for the quarter was up 23.5% on a year-over-year basis. As a group, sell-side analysts expect that Itron will post 3.61 EPS for the current year.

Insider Buying and Selling at Itron

In other news, SVP Donald L. Reeves III sold 383 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $75.37, for a total value of $28,866.71. Following the transaction, the senior vice president now owns 8,708 shares of the company’s stock, valued at $656,321.96. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, SVP Donald L. Reeves III sold 536 shares of the company’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of $87.10, for a total transaction of $46,685.60. Following the transaction, the senior vice president now owns 17,425 shares of the company’s stock, valued at $1,517,717.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Donald L. Reeves III sold 383 shares of the company’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $75.37, for a total value of $28,866.71. Following the completion of the sale, the senior vice president now owns 8,708 shares in the company, valued at $656,321.96. The disclosure for this sale can be found here. Over the last quarter, insiders sold 30,467 shares of company stock worth $2,752,520. 1.45% of the stock is owned by insiders.

Institutional Trading of Itron

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of Itron by 2.6% in the third quarter. Vanguard Group Inc. now owns 5,668,071 shares of the scientific and technical instruments company’s stock valued at $343,372,000 after acquiring an additional 142,564 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Itron by 3.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,681,573 shares of the scientific and technical instruments company’s stock valued at $126,978,000 after acquiring an additional 51,874 shares in the last quarter. Vontobel Holding Ltd. lifted its position in shares of Itron by 16.0% in the fourth quarter. Vontobel Holding Ltd. now owns 804,648 shares of the scientific and technical instruments company’s stock valued at $60,759,000 after acquiring an additional 110,849 shares in the last quarter. Guinness Asset Management LTD lifted its position in shares of Itron by 1.9% in the third quarter. Guinness Asset Management LTD now owns 635,881 shares of the scientific and technical instruments company’s stock valued at $38,504,000 after acquiring an additional 11,983 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Itron by 3.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 518,157 shares of the scientific and technical instruments company’s stock worth $39,126,000 after buying an additional 15,157 shares during the period. 96.19% of the stock is currently owned by hedge funds and other institutional investors.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.